The latest price target for Inari Medical (NASDAQ:NARI) was reported by Truist Securities on December 18, 2024. The analyst firm set a price target for $63.00 expecting NARI to rise to within 12 months (a possible 13.62% upside). 34 analyst firms have reported ratings in the last year.

The latest analyst rating for Inari Medical (NASDAQ:NARI) was provided by Truist Securities, and Inari Medical maintained their hold rating.

There is no last upgrade for Inari Medical

The last downgrade for Inari Medical Inc happened on July 18, 2024 when Needham changed their price target from N/A to N/A for Inari Medical Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Inari Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Inari Medical was filed on December 18, 2024 so you should expect the next rating to be made available sometime around December 18, 2025.

While ratings are subjective and will change, the latest Inari Medical (NARI) rating was a maintained with a price target of $50.00 to $63.00. The current price Inari Medical (NARI) is trading at is $55.45, which is within the analyst’s predicted range.